Statistics for Bivalent Ligands as Pharmacological Probes for The Melanocortin Receptors: The Bivalent Advantage
Total visits
| views | |
|---|---|
| Bivalent Ligands as Pharmacological Probes for The Melanocortin Receptors: The Bivalent Advantage | 102 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
File Visits
| views | |
|---|---|
| Lensing_umn_0130E_18115.pdf | 129 |
Top country views
| views | |
|---|---|
| United States | 39 |
| China | 12 |
| United Kingdom | 6 |
| India | 6 |
| Germany | 5 |
| Ireland | 4 |
| Russia | 4 |
| Singapore | 3 |
| Canada | 2 |
| Hong Kong SAR China | 2 |
| Italy | 2 |
| New Zealand | 2 |
| Armenia | 1 |
| Argentina | 1 |
| Australia | 1 |
| Estonia | 1 |
| South Korea | 1 |
| Moldova | 1 |
| Netherlands | 1 |
| Philippines | 1 |
| Portugal | 1 |
| Romania | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Minneapolis | 5 |
| Bengaluru | 4 |
| Longmont | 4 |
| Saint Paul | 4 |
| Dublin | 3 |
| Los Angeles | 3 |
| Regensburg | 3 |
| Storrs | 3 |
| Zhengzhou | 3 |
| Ashburn | 2 |
| Beijing | 2 |
| London | 2 |
| Shanghai | 2 |
| Singapore | 2 |
| Ann Arbor | 1 |
| Arvada | 1 |
| Baltimore | 1 |
| Bengaluru (Vasanth Nagar) | 1 |
| Boardman | 1 |
| Brooklyn | 1 |
| Bucharest | 1 |
| Central | 1 |
| Chelyabinsk | 1 |
| Chennai | 1 |
| Chernogolovka | 1 |
| Chicago | 1 |
| Christchurch | 1 |
| Dallas | 1 |
| Des Moines | 1 |
| Douglas | 1 |
| Dunedin | 1 |
| Edinburgh | 1 |
| Ellesmere Port | 1 |
| Guimarães | 1 |
| Houston | 1 |
| La Jolla | 1 |
| Liverpool | 1 |
| Livorno | 1 |
| Melbourne | 1 |
| Moscow | 1 |
| Munich | 1 |
| Naples | 1 |
| Nottingham | 1 |
| Oakland | 1 |
| Pryor | 1 |
| Salem | 1 |
| Seoul | 1 |
| Sugar Land | 1 |
| Taichung | 1 |
| Tallinn | 1 |
| Vladivostok | 1 |
| Welwyn | 1 |
| Yerevan | 1 |